Published in Rev Infect Dis on December 21, 1988
Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J (1995) 3.46
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest (1990) 2.33
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Vibrio cholerae O139 Bengal. J Clin Microbiol (1994) 2.07
Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun (1992) 1.86
Clinical implications of positive blood cultures. Clin Microbiol Rev (1989) 1.48
The human pathogenic vibrios--a public health update with environmental perspectives. Epidemiol Infect (1989) 1.26
Development of an in vitro model for study of non-O1 Vibrio cholerae virulence using Caco-2 cells. Infect Immun (1990) 1.20
Use of a synthetic oligonucleotide probe to detect strains of non-serovar O1 Vibrio cholerae carrying the gene for heat-stable enterotoxin (NAG-ST). J Clin Microbiol (1990) 1.12
Non-O1, non-O139 Vibrio cholerae bacteraemia: case report and literature review. Springerplus (2015) 1.10
Reassessment of the prevalence of heat-stable enterotoxin (NAG-ST) among environmental Vibrio cholerae non-O1 strains isolated from Calcutta, India, by using a NAG-ST DNA probe. Appl Environ Microbiol (1992) 1.09
Characterization and nucleotide sequence of CARB-6, a new carbenicillin-hydrolyzing beta-lactamase from Vibrio cholerae. Antimicrob Agents Chemother (1999) 1.03
Bacteremic cellulitis caused by non-serogroup O1 Vibrio cholerae acquired in a freshwater inland lake. J Clin Microbiol (1989) 0.97
Unusual non-serogroup O1 Vibrio cholerae bacteremia associated with liver disease. J Clin Microbiol (1989) 0.97
Occurrence of Vibrio cholerae serogroups other than O1 and O139 in Austria. Wien Klin Wochenschr (2007) 0.96
Pro-inflammatory feedback activation cycle evoked by attack of Vibrio cholerae cytolysin on human neutrophil granulocytes. Med Microbiol Immunol (2007) 0.89
Non-O1 Vibrio cholerae intestinal pathology and invasion in the removable intestinal tie adult rabbit diarrhea model. Infect Immun (1992) 0.89
Phenotypic and genotypic biotyping of environmental strains of Vibrio cholerae non-O1 isolated in Italy. Appl Environ Microbiol (1997) 0.84
Genomic and phenotypic characterization of Vibrio cholerae non-O1 isolates from a US Gulf Coast cholera outbreak. PLoS One (2014) 0.83
Spontaneous non-O1 Vibrio cholerae peritonitis after raw oyster ingestion in a patient with cirrhosis. Eur J Clin Microbiol Infect Dis (1998) 0.82
Pulmonary cholera due to infection with a non-O1 Vibrio cholerae strain. J Clin Microbiol (2006) 0.81
A cytotoxin-producing strain of Vibrio cholerae non-O1, non-O139 as a cause of cholera and bacteremia after consumption of raw clams. J Clin Microbiol (2000) 0.80
Vibrio cholerae bacteremia associated with gastrectomy. J Clin Microbiol (1990) 0.78
Quadruplex real-time PCR assay for detection and identification of Vibrio cholerae O1 and O139 strains and determination of their toxigenic potential. Appl Environ Microbiol (2009) 0.78
Massive fluid requirements and an unusual BUN/creatinine ratio for pre-renal failure in patients with cholera. PLoS One (2009) 0.78
Vibrio-associated gastroenteritis in the lower Cross-River Basin of Nigeria. J Clin Microbiol (1992) 0.77
A Case of O1 Vibrio Cholera Bacteremia and Primary Peritonitis in a Patient With Liver Cirrhosis. Gastroenterology Res (2009) 0.75
Non-O1/non-O139 Vibrio cholerae septicaemia in a Saudi man: a case report. JMM Case Rep (2017) 0.75
Rare Strain of Vibrio cholerae Septicemia in a Patient with Multiple Myeloma. Case Rep Crit Care (2015) 0.75
Cholera. Clin Microbiol Rev (1995) 12.33
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Bacteriophage therapy. Antimicrob Agents Chemother (2001) 5.16
Oxygen and the growth and metabolism of Clostridium acetobutylicum. J Gen Microbiol (1971) 4.91
Are chlamydial infections the most prevalent venereal disease? JAMA (1975) 4.79
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev (1996) 4.09
Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet (1997) 3.93
Validation of 1989 Tennessee birth certificates using maternal and newborn hospital records. Am J Epidemiol (1993) 3.67
Harlequin syndrome: the sudden onset of unilateral flushing and sweating. J Neurol Neurosurg Psychiatry (1988) 3.47
Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect Immun (1990) 3.47
The Cataract National Dataset electronic multicentre audit of 55,567 operations: risk stratification for posterior capsule rupture and vitreous loss. Eye (Lond) (2008) 3.32
Consensus statement on the live organ donor. JAMA (2000) 3.29
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Chronic-disease classification in evaluation of medical care programs. Med Care (1969) 3.23
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet (1994) 3.12
Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellates. Lancet (1998) 3.03
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest (1987) 3.03
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) (1997) 2.82
A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health (1996) 2.78
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
Spectroscopic studies of specifically deuterium labeled membrane systems. Nuclear magnetic resonance investigation of the effects of cholesterol in model systems. Biochemistry (1978) 2.71
Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis (1996) 2.68
A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet (1996) 2.59
Evaluation of DNA colony hybridization and other techniques for detection of virulence in Yersinia species. J Clin Microbiol (1989) 2.58
Comparison between effective radiation dose of CBCT and MSCT scanners for dentomaxillofacial applications. Eur J Radiol (2008) 2.53
Production of Solvents by Clostridium acetobutylicum Cultures Maintained at Neutral pH. Appl Environ Microbiol (1984) 2.51
A cohort study of summary reports of controlled trials. JAMA (1990) 2.51
A SNP resource for human chromosome 22: extracting dense clusters of SNPs from the genomic sequence. Genome Res (2001) 2.49
Back pain: a randomized clinical trial of rotational manipulation of the trunk. Br J Ind Med (1974) 2.47
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun (1995) 2.45
Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus. Infect Immun (1985) 2.42
The formation of Golgi stacks from vesiculated Golgi membranes requires two distinct fusion events. Cell (1995) 2.35
The Cataract National Dataset electronic multi-centre audit of 55,567 operations: updating benchmark standards of care in the United Kingdom and internationally. Eye (Lond) (2007) 2.35
On the permeability to weak acids and bases of the cytoplasmic membrane of Clostridium pasteurianum. Biochem Biophys Res Commun (1981) 2.32
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. N Engl J Med (1990) 2.29
Infection-control guidelines for patients with the acquired immunodeficiency syndrome (AIDS). N Engl J Med (1983) 2.26
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol Cell Biol (2000) 2.24
Illness caused by Vibrio damsela and Vibrio hollisae. Lancet (1982) 2.17
Development of executive functions through late childhood and adolescence in an Australian sample. Dev Neuropsychol (2001) 2.14
Bifunctional imidoesters as cross-linking reagents. Biochem Biophys Res Commun (1966) 2.14
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood (1994) 2.14
"Masonry arch" model of the spine. Spine (Phila Pa 1976) (1989) 2.13
Isolation of vancomycin-resistant enterococci from animal feed in USA. Lancet (1999) 2.12
Periodic patterns of actin turnover in lamellipodia and lamellae of migrating epithelial cells analyzed by quantitative Fluorescent Speckle Microscopy. Biophys J (2005) 2.11
Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol (1996) 2.10
Perioperative on-site haemoglobin determination: as accurate as laboratory values? Can J Anaesth (1996) 2.08
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry (1999) 2.07
Half-time and high-speed running in the second half of soccer. Int J Sports Med (2012) 2.03
Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol (1996) 2.01
Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods (2001) 2.01
Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med (1991) 1.97
Comparison of DNA probes and the Sereny test for identification of invasive Shigella and Escherichia coli strains. J Clin Microbiol (1986) 1.96
Stereocilia mediate transduction in vertebrate hair cells (auditory system/cilium/vestibular system). Proc Natl Acad Sci U S A (1979) 1.95
Utilization of L-threonine by a species of Arthrobacter. A novel catabolic role for "aminoacetone synthase". Biochem J (1969) 1.95
Rapid identification of Vibrio vulnificus on nonselective media with an alkaline phosphatase-labeled oligonucleotide probe. Appl Environ Microbiol (1993) 1.94
Identification of environmental Vibrio vulnificus isolates with a DNA probe for the cytotoxin-hemolysin gene. Appl Environ Microbiol (1987) 1.94
Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis. Br J Pharmacol (2009) 1.89
The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun (1991) 1.87
A precision measurement of the mass of the top quark. Nature (2004) 1.87
A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J Biol Chem (2000) 1.87
Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun (1992) 1.86
Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res (2000) 1.86
Superoxide dismutase in some obligately anaerobic bacteria. FEBS Lett (1975) 1.85
Automated DNA profiling employing multiplex amplification of short tandem repeat loci. PCR Methods Appl (1993) 1.82
Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J Bacteriol (1992) 1.81
The cytolysin gene of Vibrio vulnificus: sequence and relationship to the Vibrio cholerae E1 Tor hemolysin gene. Infect Immun (1990) 1.79
Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care (2001) 1.79
An adaptive model of sensory integration in a dynamic environment applied to human stance control. Biol Cybern (2001) 1.77
Outbreak of verocytotoxin-producing E. coli O145 and O26 infections associated with the consumption of ice cream produced at a farm, Belgium, 2007. Euro Surveill (2008) 1.74
Facial sweating in Horner's syndrome. Brain (1984) 1.73
Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond) (2005) 1.72
Investigation of an outbreak of Salmonella enteritidis gastroenteritis associated with consumption of eggs in a restaurant chain in Maryland. Am J Epidemiol (1988) 1.71
Development and testing of a nonradioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin. J Clin Microbiol (1992) 1.71
A multisensory integration model of human stance control. Biol Cybern (1999) 1.70
Directional sensitivity of individual vertebrate hair cells to controlled deflection of their hair bundles. Ann N Y Acad Sci (1981) 1.69
Molecular techniques in the study of Salmonella typhi in epidemiologic studies in endemic areas: comparison with Vi phage typing. Am J Trop Med Hyg (1986) 1.68
Seroprevalence of Helicobacter pylori in Seventh-Day Adventists and other groups in Maryland. Lack of association with diet. Arch Intern Med (1990) 1.68
The nasopalatine canal revisited using 2D and 3D CT imaging. Dentomaxillofac Radiol (2004) 1.66
Pediatric cervical spine injuries: report of 102 cases and review of the literature. J Neurosurg (2000) 1.66
Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol (2000) 1.66
Cholera in Lima, Peru, correlates with prior isolation of Vibrio cholerae from the environment. Am J Epidemiol (1997) 1.65
Vibrio metschnikovii bacteremia in a patient with cholecystitis. J Clin Microbiol (1981) 1.65
Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine. Lancet (1989) 1.61
The diagnostic efficacy of cone beam CT for impacted teeth and associated features: a systematic review. J Oral Rehabil (2011) 1.60
Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission. J Infect Dis (1993) 1.59
Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr (1998) 1.58
Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect Immun (2001) 1.58
Effect of metronidazole on hydrogen production by Clostridium acetobutylicum. Arch Mikrobiol (1972) 1.57
Deuterium nuclear magnetic resonance investigation of dimyristoyllecithin--dipalmitoyllecithin and dimyristoyllecithin--cholesterol mixtures. Biochemistry (1979) 1.56
Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype. Blood (1991) 1.56
Spo0A directly controls the switch from acid to solvent production in solvent-forming clostridia. Mol Microbiol (2000) 1.55
Antibiotic prophylaxis and cardiac surgery. A prospective double-blind comparison of single-dose versus multiple-dose regimens. Ann Intern Med (1972) 1.54
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons. J Clin Microbiol (1997) 1.52
Effects of risedronate on bone marrow adipocytes in postmenopausal women. Osteoporos Int (2010) 1.51